B. cepacia is a bacterium that can cause a potentially life threatening infection in immunocompromised individuals or those with a chronic lung condition, such as cystic fibrosis. According the Centers for Disease Control and Prevention (CDC), B. cepacia poses little risk to healthy people.
The products affected by the recall were printed with a lot number of 11G075 and an expiration date of 05/2014. Insight Pharmaceuticals discovered the bacterial contamination during its internal testing procedures and subsequently informed the Food and Drug Administration (FDA). No illnesses have been reported in connection to the products’ contamination.
“As a DEA-licensed and FDA-registered laboratory, EMSL Analytical provides reliable B. cepacia and pathogen testing services to help companies comply with regulations,”
To learn more about our pharmaceutical and consumer products testing, please visit www.EMSL.com or www.ConsumerProductsTesting.com, email info@EMSL.com, or call (800) 220-3675 x 2528.
About EMSL Analytical, Inc.
EMSL Analytical is a nationally recognized and locally focused provider of quality environmental and materials testing services and products to professionals and the general public. The company has an extensive list of accreditations from leading professional organizations as well as state and federal regulatory agencies.
# # #
EMSL Analytical Inc. is a nationally recognized accredited testing laboratory and locally focused provider of consumer product, environmental, microbiology, industrial hygiene, food and materials testing services to professionals and the general public.